throbber
Personalis, Inc.
`
`CEO Overview
`Board of Directors Meeting
`May 8, 2012
`
`Personalis Confidential May 8, 2012
`
`1
`
`Personalis EX2112
`
`

`

`CEO Overview
`
`• Company retains focus on product for 1st revenue in 2012
`– Rich to present R&D planning & progress
`4/30 ending cash above budget (Carol to review financials)
`•
`• Progress on move to new office (Carol to review – proposal to approve)
`• Continued development of ethical infrastructure (Carol to review)
`• Progress in recruiting (>60% have commercial experience)
`• Publications & public presentations
`• Four patent applications submitted based on earlier Stanford provisionals
`• Market developments – Personalis perspective
`• Accuracy development (Gold standard genome devt budget to approve)
`• Personalis laboratory strategy (outsource & insource)
`
`Personalis Confidential May 8, 2012
`
`2
`
`Personalis EX2112
`
`

`

`Publications & Upcoming Presentations
`• Seminal paper by Mike Snyder & team published in Cell :
`– Ongoing clinical use of genome-scale sequencing
`– Not just a genome once in your life
`
`• Multiple publications by Rong Chen
`
`•
`
`•
`
`JW invited to speak at CHI “The Clinical Genome” meeting
`– June 13, San Francisco
`
`JW invited to speak at Institute of Medicine meeting
`– Washington, DC, July
`
`Personalis Confidential May 8, 2012
`
`3
`
`Personalis EX2112
`
`

`

`Market Developments
`
`•
`
`Illumina / Roche
`– Financial pressure on Illumina may drive more aggressive approach to clinical potential
`– Illumina will be asked whether it is developing that opportunity as fast as Roche might
`– MiSeq moving to 510k; Cancer-gene pullout panel released
`– 2 x 250 reads now “summer” and only MiSeq
`
`• Complete Genomics
`– Delivery times being quoted as 12-16 weeks
`
`• Oxford Nanopore
`– No data seen yet, but tentative meeting in UK in July
`
`•
`
`Life Ion Proton
`– Expect HapMap genome for analysis in the next month
`
`Personalis Confidential May 8, 2012
`
`4
`
`Personalis EX2112
`
`

`

`Overview of Personalis Accuracy Program
`
`Characterize errors
`
`Informatic Solutions
`
`Lab, Content Solutions
`
`Analysis
`Rates by variant type & Q-score
`Underlying mechanisms
`Medical interpretation impact
`Regulatory impact
`
`Methods
`Comparison with literature
`Studies on limited regions
`Whole genome analysis:
`Single genome metrics
`Same person twice
`Family inheritance (MIE)
`Platform comparison
`Arrays
`ILMN / CGI / Ion T…
`Sanger capillary
`
`Prioritize solutions
`Bio-informatic approaches
`Laboratory approaches
`Content approaches
`
`Advances in 3rd party alg’s
`Aligner for > 200bp reads
`New versions, current alg’s
`Other alg’s (e.g. lobSTR)
`
`Advances in our alg’s:
`SV’s : Zygocity, accuracy
`Combine SV’s & SNP’s
`Broader use of Breakseq
`
`New Personalis alg’s
`Alignment degeneracy
`Genome-aware alignment
`VNTR-specific
`
`Advances in reference
`Ethnic major-allele ref’s
`Iterative
`Admixed
`InDel’s / SV’s
`
`Flag or Filter Out
`For problems not yet solved
`
`Combine technologies
`WGS + exome
`Longer reads and/or inserts
`Multi-vendor
`Arrays (genotypes & SV’s)
`Electrophoretic sizing
`Sanger validation
`
`Content-based semi-custom
`Array (genotypes & SV’s)
`Pullout
`
`Custom sample preps
`Problematic motifs
`Degenerate regions
`Phasing
`
`Content
`Gold standard genomes
`Known healthy genomes
`
`Personalis Confidential May 8, 2012
`
`5
`
`Personalis EX2112
`
`

`

`Example of process variation in genome sequencing
`Four individuals had blood drawn together at the same hospital, sent to the same
`CLIA / CAP accredited lab, and sequenced on the same set of instruments.
`
`Personalis Confidential May 8, 2012
`
`6
`
`Personalis EX2112
`
`

`

`Occurrence of bases with very low raw quality scores
`deviates markedly from a random (binomial) model
`
`# Reads below quality threshold (Loci with 30-40x coverage)
`
`Profile of systematic errors is remarkably similar between these two genomes
`
`Personalis Confidential May 8, 2012
`
`7
`
`Personalis EX2112
`
`

`

`Region with “normal”
`sequence
`
`Region with “problematic”
`Sequence motif
`
`Tools to search for systematic errors across the genome, with their underlying
`mechanisms of action, will be followed by bio-informatic flags and (more
`importantly) bio-informatic and laboratory solutions.
`
`Personalis Confidential May 8, 2012
`
`8
`
`Personalis EX2112
`
`

`

`Progression of Genome Data Sets for Accuracy Studies
`
`Founder Genomes
`
`Downloading
`
`Custom Sequenced
`
`West quartet (2009)
`MIE analysis:
`SNP (Dewey)
`SV’s (Manual, WG)
`InDel (TBD)
`Anecdotal error studies on
`portions of the genome:
`Phenomena
`Error rates
`Underlying mechanisms
`GA IIx vs HiSeq (early 2011)
`
`Snyder son/mother
`Data behind publications:
`Illumina vs CGI
`Snyderome paper
`Some inheritance validation
`
`HapMap NA12878
`Broad data set (late 2010):
`Hi-Seq 2x100
`10 PE insert lengths
`Total coverage > 500
`Same person “twice”:
`Same library
`Different library
`High coverage
`SV validation (Snyder)
`Fluor. Array data
`HapMap genotypes
`Some relatives’ data
`available
`
`Korean PGP
`40 HiSeq 2x100 genomes
`
`CEPH1463
`3 generations, 17 people
`Mother is HapMap NA12878
`To be “gold std”
`All 17 sequenced by CGI
`Test-bed for Personalis max
`accuracy combination of
`technologies
`Use to assess other tech’s:
`Ion Proton
`Oxford Nanopore
`MiSeq 2x250
`Anonymous samples
`(ethics)
`No Personalis relationship
`
`Venter Genome
`Only individual whole
`genome on Sanger
`technology
`
`Personalis Confidential May 8, 2012
`
`9
`
`Personalis EX2112
`
`

`

`Segmentation of the 17-member pedigree by priority for sequencing
`
`Personalis Confidential May 8, 2012
`
`10
`
`Personalis EX2112
`
`

`

`All 11
`children
`
`Several
`optimal
`subsets
`with 5 of
`the 11
`children
`
`Mendelian Inheritance Error analysis can be confounded by genomic variation
`induced by the cell culture process. Being able to see each parental allele in two
`separate children should let us separate most of these errors from sequencing
`artifacts, letting us better identify them.
`
`Personalis Confidential May 8, 2012
`
`11
`
`Personalis EX2112
`
`

`

`Personalis Confidential May 8, 2012
`
`12
`
`Personalis EX2112
`
`

`

`Personalis Laboratory Strategy
`
`•
`
`Laboratory goals:
`– Direct relationship with the customer
`– Quality control, sample to results (important for research and later clinical)
`– Position as “Value-Added Genome”, not “a bio-informatics company”
`– Offer a superior genome, by combining technologies from multiple companies
`– Develop superior sample preps, esp based on Personalis content
`• Outsourcing:
`– Whole genome sequencing service pricing now < reagents to do it yourself
`– Avoid infrastructure costs (instruments, initial computation, staffing)
`– Turn-around time is a disadvantage (quotes at 12-16 weeks)
`– Other assays we can outsource:
`• Arrays (standard & semi-custom)
`• Karyotyping
`• Exomes, RNAseq
`• Personalis lab
`– Receive, de-identify samples
`– QC, sample tracking
`– Ship aliquots to multiple vendors
`– Validations following primary analysis
`– Develop custom sample preps
`
`Personalis Confidential May 8, 2012
`
`13
`
`Personalis EX2112
`
`

`

`Next : VP Finance report
`
`Personalis Confidential May 8, 2012
`
`14
`
`Personalis EX2112
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket